Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BALCHEM CORPBCPC · Entity 3839 | Vice President | November 12, 2019 | November 13, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BALCHEM CORP
Report date November 12, 2019 · Filed November 13, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 18,775 |
Reported balance
After 2019-11-12 transaction · row 1
1 source rowRow 1 · 2019-11-12 · Gift · Disposed 240 · Balance 18,775 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 12, 2019 Filed Nov 13, 2019 18:19 UTC | BALCHEM CORP BCPC · Entity 3839 | GiftCommon Stock | 240 | $102.87 | $24,688.80 |
DisclosureSEC source: 0001140361-19-020424 · form4.xml · nonDerivative · entry 1 LUDWIG DAVID F · CIK 0001209495 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,775 Read SEC document |
| August 30, 2019 Filed Aug 30, 2019 18:35 UTC | BALCHEM CORP BCPC · Entity 3839 | Exercise / conversionStock Option · Derivative | 10,688 | $0.00 Strike: $21.39 | $0.00 |
DisclosureSEC source: 0001246360-19-002031 · form.xml · derivative · entry 6 LUDWIG DAVID F · CIK 0001209495 · Vice President, Specialty & In 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,688 shares Expires 2019-12-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 30, 2019 Filed Aug 30, 2019 18:35 UTC | BALCHEM CORP BCPC · Entity 3839 | SaleCommon Stock | 10,688 | $90.00 | $961,920.00 |
DisclosureSEC source: 0001246360-19-002031 · form.xml · nonDerivative · entry 4 LUDWIG DAVID F · CIK 0001209495 · Vice President, Specialty & In 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,976 Read SEC document |
| August 30, 2019 Filed Aug 30, 2019 18:35 UTC | BALCHEM CORP BCPC · Entity 3839 | Exercise / conversionCommon Stock | 10,688 | $21.39 | $228,616.32 |
DisclosureSEC source: 0001246360-19-002031 · form.xml · nonDerivative · entry 3 LUDWIG DAVID F · CIK 0001209495 · Vice President, Specialty & In 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,664 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 29, 2019 Filed Aug 30, 2019 18:35 UTC | BALCHEM CORP BCPC · Entity 3839 | Exercise / conversionStock Option · Derivative | 2,062 | $0.00 Strike: $21.39 | $0.00 |
DisclosureSEC source: 0001246360-19-002031 · form.xml · derivative · entry 5 LUDWIG DAVID F · CIK 0001209495 · Vice President, Specialty & In 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,688 Underlying: Common Stock · 2,062 shares Expires 2019-12-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 29, 2019 Filed Aug 30, 2019 18:35 UTC | BALCHEM CORP BCPC · Entity 3839 | SaleCommon Stock | 2,062 | $90.00 | $185,580.00 |
DisclosureSEC source: 0001246360-19-002031 · form.xml · nonDerivative · entry 2 LUDWIG DAVID F · CIK 0001209495 · Vice President, Specialty & In 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,976 Read SEC document |
| August 29, 2019 Filed Aug 30, 2019 18:35 UTC | BALCHEM CORP BCPC · Entity 3839 | Exercise / conversionCommon Stock | 2,062 | $21.39 | $44,106.18 |
DisclosureSEC source: 0001246360-19-002031 · form.xml · nonDerivative · entry 1 LUDWIG DAVID F · CIK 0001209495 · Vice President, Specialty & In 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,038 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 19, 2019 Filed Feb 20, 2019 22:22 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 828 | $87.32 | $72,300.96 |
DisclosureSEC source: 0001140361-19-003563 · form4.xml · nonDerivative · entry 1 LUDWIG DAVID F · CIK 0001209495 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,858 F1 · shares: On February 19, 2015, Balchem Corporation (the "Company") granted 1,695 restricted shares under the Company's Management Long Term Incentive Program. The stock was subject to a repurchase option in favor of the Company and to restrictions on transfer until it vested in accordance with the provisions of the Restricted Stock Purchase Agreement. On February 19, 2019, 828 of the 1,695 shares that vested February 19, 2019 were withheld to cover withholding taxes due upon vesting. F2 · balance_after: Beneficial Ownership reconciled to reflect this transaction and those reported on Form 4 filed on February 15, 2018. Read SEC document |
| February 13, 2019 Filed Feb 15, 2019 20:41 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantStock Option · Derivative | 4,000 | $0.00 Strike: $84.09 | $0.00 |
DisclosureSEC source: 0001140361-19-003368 · form4.xml · derivative · entry 4 LUDWIG DAVID F · CIK 0001209495 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,081 Underlying: Common Stock · 4,000 shares Expires 2029-02-13 F4 · derivative.exercise_date: Options vest 20% year 1; 40% year 2; and 40% year 3. Read SEC document |
| February 13, 2019 Filed Feb 15, 2019 20:41 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 797 | $84.09 | $67,019.73 |
DisclosureSEC source: 0001140361-19-003368 · form4.xml · nonDerivative · entry 3 LUDWIG DAVID F · CIK 0001209495 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,549 F3 · shares: 785 of the 1,480 shares that vested February 13, 2019 were withheld to cover withholding taxes due upon vesting. Read SEC document |
| February 13, 2019 Filed Feb 15, 2019 20:41 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 1,503 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-19-003368 · form4.xml · nonDerivative · entry 2 LUDWIG DAVID F · CIK 0001209495 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,343 F2 · shares: Acquired upon the settlement of performance shares granted on February 22, 2016 based upon a predetermined EBITDA performance target and total shareholder return against the Russell 2000 Index over a three-year period under the Company's Second Amended and Restated 1999 Stock Plan (as amended and restated effective June 20, 2013) as a result of the satisfaction of those performance criteria. Read SEC document |
| February 13, 2019 Filed Feb 15, 2019 20:41 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 860 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-19-003368 · form4.xml · nonDerivative · entry 1 LUDWIG DAVID F · CIK 0001209495 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,840 F1 · shares: Ownership of the restricted stock does not vest in Reporting person until three years from the grant date and is further subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. Read SEC document |
| May 10, 2018 Filed May 11, 2018 17:45 UTC | BALCHEM CORP BCPC · Entity 3839 | OtherCommon Stock | 14,401 | $93.55 | $1,347,213.55 |
DisclosureSEC source: 0001140361-18-022987 · form4.xml · nonDerivative · entry 1 LUDWIG DAVID F · CIK 0001209495 · Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · 401(k) Plan Disclosed balance after: 17,910 F1 · kind: Intra-plan transfer from the Balchem Common Stock Fund to another fund within the respective plan. F1 · shares: Intra-plan transfer from the Balchem Common Stock Fund to another fund within the respective plan. Read SEC document |
| February 26, 2018 Filed Mar 13, 2018 00:49 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 283 | $76.21 | $21,567.43 |
DisclosureSEC source: 0001140361-18-013133 · form4.xml · nonDerivative · entry 1 LUDWIG DAVID F · CIK 0001209495 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,301 F1 · shares: On February 26, 2014, Balchem Corporation (the "Company") granted 577 restricted shares under the Company's Management Long Term Incentive Program. The stock was subject to a repurchase option in favor of the Company and to restrictions on transfer until it vested in accordance with the provisions of the Restricted Stock Purchase Agreement on February 26, 2018. 283 of the 577 shares that vested February 26, 2018 were withheld to cover withholding taxes due upon vesting. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 23:15 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantStock Option · Derivative | 3,720 | $0.00 Strike: $74.57 | $0.00 |
DisclosureSEC source: 0001140361-18-009162 · form4.xml · derivative · entry 4 LUDWIG DAVID F · CIK 0001209495 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,720 Underlying: Common Stock · 3,720 shares Expires 2028-02-15 F4 · derivative.exercise_date: Options vest 20% year 1; 40% year 2; and 40% year 3. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 23:15 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 1,381 | $74.57 | $102,981.17 |
DisclosureSEC source: 0001140361-18-009162 · form4.xml · nonDerivative · entry 3 LUDWIG DAVID F · CIK 0001209495 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,824 F3 · shares: 1,381 of the 2,698 shares that vested February 15, 2018 were withheld to cover withholding taxes due upon vesting. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 23:15 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 2,719 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-009162 · form4.xml · nonDerivative · entry 2 LUDWIG DAVID F · CIK 0001209495 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,205 F2 · shares: Acquired upon the settlement of performance shares granted on February 19, 2018 based upon a predetermined EBITDA performance target and total shareholder return against the Russell 2000 Index over a three-year period under the Company's Second Amended and Restated 1999 Stock Plan (as amended and restated effective June 20, 2013) as a result of the satisfaction of those performance criteria. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 23:15 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 930 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-009162 · form4.xml · nonDerivative · entry 1 LUDWIG DAVID F · CIK 0001209495 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,486 F1 · shares: Ownership of the restricted stock does not vest in Reporting person until four years from the grant date and is further subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. Read SEC document |
| December 14, 2017 Filed Dec 15, 2017 14:23 UTC | BALCHEM CORP BCPC · Entity 3839 | GiftCommon Stock | 310 | $80.94 | $25,091.40 |
DisclosureSEC source: 0001140361-17-046323 · form4.xml · nonDerivative · entry 1 LUDWIG DAVID F · CIK 0001209495 · VP/GM Spec. & Indust. Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,336 Read SEC document |
| February 21, 2017 Filed Feb 24, 2017 01:34 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantEmployee Stock Option (right to buy) · Derivative | 5,720 | $0.00 Strike: $85.40 | $0.00 |
DisclosureSEC source: 0001140361-17-008935 · doc1.xml · derivative · entry 1 LUDWIG DAVID F · CIK 0001209495 · VP/Gen Mgr/ARC Spec Prods 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,720 Underlying: Common Stock · 0 shares Expires 2027-02-21 F1 · derivative.exercise_date: Options vest 20% year 1; 40% year 2; and 40% year 3 . Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 15:57 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 1,633 | $85.40 | $139,458.20 |
DisclosureSEC source: 0001140361-17-008756 · doc1.xml · nonDerivative · entry 1 LUDWIG DAVID F · CIK 0001209495 · VP/Gen Mgr/ARC Spec Prods 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,013 F1 · security: On February 19, 2013, the Company granted 3.081 restricted shares under the Company's Management Long Term Incentive Program. The stock was subject to a repurchase option in favor of the Issuer and to restrictions on transfer until it vested in accordance with the provisions of the Restricted Stock Purchase Agreement on February 19, 2017. 1,633 of the 3,081 shares that vested February 19, 2017 were withheld to cover withholding taxes due upon vesting. F1 · shares: On February 19, 2013, the Company granted 3.081 restricted shares under the Company's Management Long Term Incentive Program. The stock was subject to a repurchase option in favor of the Issuer and to restrictions on transfer until it vested in accordance with the provisions of the Restricted Stock Purchase Agreement on February 19, 2017. 1,633 of the 3,081 shares that vested February 19, 2017 were withheld to cover withholding taxes due upon vesting. F2 · balance_after: This filing amends the "Amount of Securities Beneficially Owned Following Reported Transaction" to include the most current amount of shares owned directly by Mr. Ludwig in his 401(k)/profit sharing account. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.